Literature DB >> 17467407

Sleep quality in advanced cancer patients.

Kyriaki Mystakidou1, Efi Parpa, Eleni Tsilika, Maria Pathiaki, Elisabeth Patiraki, Antonis Galanos, Lambros Vlahos.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the sleep quality of advanced cancer patients and its relationship with pain, depression, and hopelessness.
METHODS: The participants were 102 advanced cancer patients who were on palliative treatment. Patients completed a sleep quality instrument, the Pittsburgh Sleep Quality Index (PSQI); a pain assessment tool, the Greek Brief Pain Inventory; a self-report measure of depression, the Beck Depression Inventory; and, finally, the Beck Hopelessness Scale.
RESULTS: Multiple regression analyses (forward method) have shown that hopelessness (P=.003), "interference of pain with mood" (P<.0005), and strong opioids (P=.010) seemed to influence patients' sleep quality (PSOI). In an additional regression analysis (enter method), the PSQI is significantly related to opioids (P=.013), hopelessness (P=.035), and "interference of pain with mood" (P=.004).
CONCLUSION: Hopelessness, pain treatment, and "interference of pain with mood" may influence the quality of sleep in advanced stages of cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17467407     DOI: 10.1016/j.jpsychores.2006.11.008

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  21 in total

1.  Rest/activity rhythm is related to the coexistence of pain and sleep disturbance among advanced cancer patients with pain.

Authors:  Chen-Lai Ma; Wen-Pei Chang; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2013-09-01       Impact factor: 3.603

2.  Psychometric evaluation and feasibility of the Greek Pittsburgh Sleep Quality Index (GR-PSQI) in patients with cancer receiving chemotherapy.

Authors:  Grigorios C Kotronoulas; Constantina N Papadopoulou; Anastasia Papapetrou; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2010-10-23       Impact factor: 3.603

3.  Problems sleeping with prostate cancer: exploring possible risk factors for sleep disturbance in a population-based sample of survivors.

Authors:  Rebecca Maguire; Frances J Drummond; Paul Hanly; Anna Gavin; Linda Sharp
Journal:  Support Care Cancer       Date:  2019-01-09       Impact factor: 3.603

4.  Sleep quality and its association with delirium among veterans enrolled in hospice.

Authors:  Christopher G Slatore; Elizabeth R Goy; Daniel J Oʼhearn; Eilis A Boudreau; Jean P OʼMalley; Dawn Peters; Linda Ganzini
Journal:  Am J Geriatr Psychiatry       Date:  2012-04       Impact factor: 4.105

5.  Sleep quality in long-term survivors of head and neck cancer: preliminary findings.

Authors:  Na Li; Takafumi Otomaru; Hisashi Taniguchi
Journal:  Support Care Cancer       Date:  2017-07-09       Impact factor: 3.603

6.  Factors affecting quality of life in cancer patients undergoing chemotherapy.

Authors:  M S Heydarnejad; Dehkordi A Hassanpour; Dehkordi K Solati
Journal:  Afr Health Sci       Date:  2011-06       Impact factor: 0.927

7.  Differences in sleep disturbance and fatigue between patients with breast and prostate cancer at the initiation of radiation therapy.

Authors:  Kristin Garrett; Anand Dhruva; Theresa Koetters; Claudia West; Steven M Paul; Laura B Dunn; Bradley E Aouizerat; Bruce A Cooper; Marylin Dodd; Kathryn Lee; William Wara; Patrick Swift; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2011-03-31       Impact factor: 3.612

8.  Development of a mouse model for assessing fatigue during chemotherapy.

Authors:  Maria A Ray; Rita A Trammell; Steve Verhulst; Sophia Ran; Linda A Toth
Journal:  Comp Med       Date:  2011-04       Impact factor: 0.982

9.  Improving sleep quality for cancer patients: benefits of a home-based exercise intervention.

Authors:  Mei-Feng Tang; Tsan-Hon Liou; Chia-Chin Lin
Journal:  Support Care Cancer       Date:  2009-10-16       Impact factor: 3.603

Review 10.  Fatigue and sleep during cancer and chemotherapy: translational rodent models.

Authors:  Maria Ray; Laura Q Rogers; Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.